Canadian health regulator on Thursday raised concerns about the large quantity of medical marijuana people were growing at home, after its data showed a significant jump in daily average production permitted by health care practitioners.

While the practitioners can allow registered patients to grow limited amount at home for personal use, the regulator's findings show that such authorizations rose to a staggering 36.2 grams by the end of March, compared with 25.2 grams in October 2018.

Meanwhile, average purchases by registered patients, who can buy pot from licensed producers and federal medical sellers, have stayed as low as 2 to 2.1 grams every month, data showed.

Making predictions about California’s marijuana industry was a challenge even before a global pandemic changed everything.

It’s not just that the legal cannabis market, which launched three years ago in California, is so new. It’s also the singularity of an industry in which licensed, legal operators still compete against a much larger illicit market, even as the industry’s core consumer product — which is medicine for some people — remains illegal at the federal level.

Read entire article at Technical 420

With 2020 coming to a close in less than two weeks, we want to highlight one of the most significant themes of the year as it relates to the cannabis industry.

The theme is the European Union (EU) and we believe that the continent made significant strides in 2020. Although the EU cannabis market recorded impressive growth when compared to 2019, the growth came in below broker-dealer expectations and we believe that this put pressure on the companies that are highly focused on it.

Following the results of the 2020 presidential election, cannabis advocates across the nation breathed a sigh of relief; for the first time in our history, cannabis decriminalization was being supported by the party in office. Since 2012, 15 states and Washington, DC, have legalized cannabis for adults over the age of 21. And 36 states have legalized medical cannabis — meaning that a majority of Americans now have some form of access to cannabis, whether medically or recreationally. On December 4th, the House passed the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, a historic bill which will remove cannabis from the Controlled Substances Act and serves as the first step in ultimately deciding the fate of federal decriminalization in the United States. 

On Friday December 11, 2020 at approximately 9:20 p.m., two Hawkesbury OPP Constables were on patrol in the Town of Hawkesbury when they intercepted a black 2007 Mazda 3 on McGill Street.

Investigation revealed that the driver was in violation of his court conditions. The driver was arrested and a further search of the vehicle led to the discovery of a large quantity of suspected methamphetamine.

Officers seized more than 5,290 methamphetamine (speed) tablets.

The driver, a 25 year-old man from Victoriaville Québec, was arrested and charged under the Controlled Drugs and Substances Act with “Possession of a Schedule I substance for the purpose of Trafficking – Methamphetamine”.

(Reuters) - Canadian health regulator on Thursday raised concerns about the large quantity of medical marijuana people were growing at home, after its data showed a significant jump in daily average production permitted by health care practitioners.

While the practitioners can allow registered patients to grow limited amount at home for personal use, the regulator’s findings show that such authorizations rose to a staggering 36.2 grams by the end of March, compared with 25.2 grams in October 2018.

Meanwhile, average purchases by registered patients, who can buy pot from licensed producers and federal medical sellers, have stayed as low as 2 to 2.1 grams every month, data showed.

Two weeks ago, I reported on the landmark ruling by the Court of Justice of the European Union (the CJEU) that cannabidiol (CBD) derived from the entire hemp plant is not a narcotic under the U.N. Single Convention on Narcotic Drugs of 1961 (the Single Convention); and thus, should be freely traded between European Union (EU) member states.

The NBA will suspend random testing for marijuana for the 2020-21 season and focus its attention on performance-enhancing products and drugs of abuse.

Marijuana has been stuck on the top of the NBA’s banned substances list for a long time, but some recent changes in policy could indicate that it might not be for long. Now that more than half the nation has legalized marijuana for medicinal and recreational purposes, officials overseeing professional basketball’s inner workings are starting to lose interest in players who smoke weed.